<DOC>
	<DOC>NCT01182077</DOC>
	<brief_summary>The objective of the study is to characterize the effect of multiple doses of ASP015K on the pharmacokinetics of a single dose of midazolam.</brief_summary>
	<brief_title>A Study to Assess Drug Interaction of ASP015K and Midazolam</brief_title>
	<detailed_description />
	<mesh_term>Midazolam</mesh_term>
	<criteria>Subject weighing at least 45kg and BMI of 1832 kg/m2, inclusive If female, subject is at least 2 years post menopausal or is surgically sterile per documentation provided by a third party medical professional and the subject is not pregnant as documented by a negative serum pregnancy test If male, subject agrees to sexual abstinence, is surgically sterile, or is using a medically acceptable method to prevent pregnancy during the study period History of any clinically significant disorder, disease or malignancy excluding nonmelanoma skin cancer Recent history (within 6 months) of drug or alcohol abuse or positive urine screen for drugs of abuse/illegal drugs Treatment with prescription drugs or complementary and alternative medicines (CAM) within 14 days prior to study drug administration, or over the counter medication within 1 week prior to study drug administration A symptomatic, viral, bacterial or fungal infection within 1 week prior to clinic checkin Positive test for hepatitis C antibody, or positive test for hepatitis B surface antigen (HBsAg) History of the human immunodeficiency virus (HIV) antibody Positive tuberculosis (TB) skin test or Quantiferon Gold test Vaccinated within the last 30 days prior to study drug administration Received an experimental agent within 30 days or five halflives, whichever is longer, prior to study drug administration Any significant blood loss, donated one unit (450 mL) of blood or more, or received a transfusion of any blood or blood products within 60 days or donated plasma within 7 days prior to clinic admission Absolute neutrophil count (ANC) &lt;2500 cells/mm3</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>ASP015K</keyword>
	<keyword>midazolam</keyword>
	<keyword>healthy volunteers</keyword>
</DOC>